People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

Iron deficiency may be linked to non-dialysis-dependent chronic kidney disease and mortality in patients without anemia, according to results of a nationwide cohort study.While iron is a key component ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and ...

Many older people develop chronic kidney disease and are also likely to be on cholesterol-lowering drugs known as statins.

Statins, a class of cholesterol-lowering drugs, have no effect on kidney function, a research team led by the University of Iowa has found.

Statins, a class of cholesterol-lowering drugs, have no effect on kidney function, a research team led by the University of ...

In line with trial results, real-world data suggest GLP-1 receptor agonists have certain benefits in patients with moderate to severe chronic kidney disease (CKD).

A University of Iowa research team has found that a class of cholesterol-lowering drugs have no effect on kidney function.

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

The Creve Coeur-based company is developing the use of proprietary fluorescent tracer agents as a noninvasive way to test ...